Cargando…
Reversal of Liver Fibrosis
Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the cellula...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702953/ https://www.ncbi.nlm.nih.gov/pubmed/19568569 http://dx.doi.org/10.4103/1319-3767.45072 |
_version_ | 1782168820024082432 |
---|---|
author | Ismail, Mona H. Pinzani, Massimo |
author_facet | Ismail, Mona H. Pinzani, Massimo |
author_sort | Ismail, Mona H. |
collection | PubMed |
description | Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the cellular and molecular level, this progressive process is characterized by cellular activation of hepatic stellate cells and aberrant activity of transforming growth factor-β with its downstream cellular mediators. Liver biopsy has been the reference test for assessment of hepatic fibrosis, but because of its limitations, noninvasive markers of liver fibrosis were developed. Liver fibrosis or cirrhosis was considered irreversible in the past but progress of research on the molecular pathogenesis of liver fibrosis has shown that hepatic cellular recovery is possible. Currently, no acceptable therapeutic strategies exist, other than removal of the fibrogenic stimulus, to treat this potentially devastating disease. |
format | Text |
id | pubmed-2702953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-27029532009-06-30 Reversal of Liver Fibrosis Ismail, Mona H. Pinzani, Massimo Saudi J Gastroenterol New Horizon Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the cellular and molecular level, this progressive process is characterized by cellular activation of hepatic stellate cells and aberrant activity of transforming growth factor-β with its downstream cellular mediators. Liver biopsy has been the reference test for assessment of hepatic fibrosis, but because of its limitations, noninvasive markers of liver fibrosis were developed. Liver fibrosis or cirrhosis was considered irreversible in the past but progress of research on the molecular pathogenesis of liver fibrosis has shown that hepatic cellular recovery is possible. Currently, no acceptable therapeutic strategies exist, other than removal of the fibrogenic stimulus, to treat this potentially devastating disease. Medknow Publications 2009-01 /pmc/articles/PMC2702953/ /pubmed/19568569 http://dx.doi.org/10.4103/1319-3767.45072 Text en © The Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | New Horizon Ismail, Mona H. Pinzani, Massimo Reversal of Liver Fibrosis |
title | Reversal of Liver Fibrosis |
title_full | Reversal of Liver Fibrosis |
title_fullStr | Reversal of Liver Fibrosis |
title_full_unstemmed | Reversal of Liver Fibrosis |
title_short | Reversal of Liver Fibrosis |
title_sort | reversal of liver fibrosis |
topic | New Horizon |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702953/ https://www.ncbi.nlm.nih.gov/pubmed/19568569 http://dx.doi.org/10.4103/1319-3767.45072 |
work_keys_str_mv | AT ismailmonah reversalofliverfibrosis AT pinzanimassimo reversalofliverfibrosis |